Molecule Information
General Information of the Molecule (ID: Mol01099)
Name |
Tethering factor for nuclear proteasome STS1 (STS1)
,Saccharomyces cerevisiae
|
||||
---|---|---|---|---|---|
Synonyms |
Dumbbell former protein 8; SEC23 suppressor 1; DBF8; SSM5; YIR011C; YIB11C
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
STS1
|
||||
Gene ID | |||||
Sequence |
MMGFEWGFKPSSKITQSTVSSQGTGNVMIPTAGVKQKRRYANEEQEEEELPRNKNVMKYG
GVSKRRPQPGSLIRGQPLPLQRGMELMNKNQLQQLLVDLMTKHPEIQQSVHTRVIGLDFS IQKCLDMLKQKSEAVYQSIPYNRSYESNKLDDYAFVRMKPQILEFLNCLVDFILDNIPPR LENLHASLKFLDICTELVIKLPRFELASNNYYYDKCIEQLSHVWCTLIEHVARDRIILLA DNSSVWKSHMTRLQVYNEHSNGLLERPLQLFKSLDMGSPSAASSSTLSLQESIIYHHDTM TANENNNNSGSAATDSPFN Click to Show/Hide
|
||||
Function |
Involved in ubiquitin-mediated protein degradation. Regulatory factor in the ubiquitin/proteasome pathway that controls the turnover of proteasome substrates. Targets proteasomes to the nucleus and facilitates the degradation of nuclear proteins. Required for efficient chromosome segregation. Restores protein transport and ribosomal RNA stability.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
3 drug(s) in total
Fluconazole
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Recurrent oropharyngeal candidiasis | [1] | |||
Sensitive Disease | Recurrent oropharyngeal candidiasis [ICD-11: 1F23.6] | |||
Sensitive Drug | Fluconazole | |||
Molecule Alteration | Deletion mutation | Deleteion |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Saccharomyces cerevisiae strain | 4932 | ||
Experiment for Molecule Alteration |
qPCR; TEF3 probe assay | |||
Experiment for Drug Resistance |
Microbroth dilution MIC assay | |||
Mechanism Description | The S. cerevisiae sts1 deletion mutant was hypersusceptible to all three azole derivatives used in the study, which is a strong indication that Sts1, a close homolog of Cdr1, is implicated in their transport. |
Itraconazole
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Recurrent oropharyngeal candidiasis | [1] | |||
Sensitive Disease | Recurrent oropharyngeal candidiasis [ICD-11: 1F23.6] | |||
Sensitive Drug | Itraconazole | |||
Molecule Alteration | Deletion mutation | Deleteion |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Saccharomyces cerevisiae strain | 4932 | ||
Experiment for Molecule Alteration |
qPCR; TEF3 probe assay | |||
Experiment for Drug Resistance |
Microbroth dilution MIC assay | |||
Mechanism Description | The S. cerevisiae sts1 deletion mutant was hypersusceptible to all three azole derivatives used in the study, which is a strong indication that Sts1, a close homolog of Cdr1, is implicated in their transport. |
Ketoconazole
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Recurrent oropharyngeal candidiasis | [1] | |||
Sensitive Disease | Recurrent oropharyngeal candidiasis [ICD-11: 1F23.6] | |||
Sensitive Drug | Ketoconazole | |||
Molecule Alteration | Deletion mutation | Deleteion |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Saccharomyces cerevisiae strain | 4932 | ||
Experiment for Molecule Alteration |
qPCR; TEF3 probe assay | |||
Experiment for Drug Resistance |
Microbroth dilution MIC assay | |||
Mechanism Description | The S. cerevisiae sts1 deletion mutant was hypersusceptible to all three azole derivatives used in the study, which is a strong indication that Sts1, a close homolog of Cdr1, is implicated in their transport. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.